XBIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xenetic Biosciences Inc (XBIO) is not a strong buy for a beginner, long-term investor at this time. The lack of positive trading signals, weak financial performance, and absence of significant catalysts suggest that holding off on investment is prudent.
The technical indicators are mixed. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is negative and expanding downward (-0.024), and the RSI is neutral at 41.4. The stock is trading near its pivot level of 3.298, with key resistance at 3.579 and support at 3.018. Overall, there is no clear bullish trend.
The company's gross margin remains strong at 100%, and revenue increased by 18.11% YoY in Q4 2025.
Net income dropped significantly by -45.09% YoY, and EPS declined by -60.29% YoY. There are no recent news updates, no significant hedge fund or insider trading trends, and no recent congress trading data. Additionally, the stock trend analysis suggests a potential decline of -7.38% over the next month.
In Q4 2025, revenue increased to $766,296 (up 18.11% YoY), but net income dropped to -$579,076 (down -45.09% YoY). EPS also declined to -0.27 (down -60.29% YoY), reflecting worsening profitability despite stable gross margins at 100%.
No analyst rating or price target data available.
